US6664292B2 - Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor - Google Patents

Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor Download PDF

Info

Publication number
US6664292B2
US6664292B2 US09/873,773 US87377301A US6664292B2 US 6664292 B2 US6664292 B2 US 6664292B2 US 87377301 A US87377301 A US 87377301A US 6664292 B2 US6664292 B2 US 6664292B2
Authority
US
United States
Prior art keywords
nail
treatment
methods
compositions
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/873,773
Other versions
US20020183387A1 (en
Inventor
Mark H. Bogart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/873,773 priority Critical patent/US6664292B2/en
Application filed by Individual filed Critical Individual
Priority to PCT/US2002/014007 priority patent/WO2002098402A1/en
Priority to EP02726836A priority patent/EP1401421B1/en
Priority to DE60235545T priority patent/DE60235545D1/en
Priority to AT02726836T priority patent/ATE459349T1/en
Priority to JP2003501442A priority patent/JP2004532882A/en
Priority to ES02726836T priority patent/ES2343352T3/en
Priority to CA2449312A priority patent/CA2449312C/en
Publication of US20020183387A1 publication Critical patent/US20020183387A1/en
Application granted granted Critical
Publication of US6664292B2 publication Critical patent/US6664292B2/en
Priority to AU2008201244A priority patent/AU2008201244A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Definitions

  • the present invention relates to methods for treating pathological conditions of the nail and compositions useful therefor.
  • the invention relates to methods for treating conditions resulting from bacterial or fungal infections of the nail, and compositions useful therefor.
  • topical administration of pharmaceutically active agents has often been employed for treating pathological conditions. Many of the concerns associated with other types of administration can often be avoided by topically administering an active agent to a subject in need thereof. For example, reliable delivery of a pharmaceutically active agent to organs or tissues in need thereof via oral administration is often difficult due to variable rates of absorption and metabolism associated with oral delivery. In contrast, topical administration of a pharmaceutically active agent can provide high doses of the active agent directly to the infected area, and often minimizes side effects.
  • onychomycosis A particular condition of the nail which remains ineffectively treated is onychomycosis. This condition is a fungal infection of the nail most frequently caused by dermatophytes and molds. Indeed, onychomycosis refers to any dermatophyte infection of the nail plate and includes infection of nails by any fungus, such as yeast, molds, and the like. Onychomycosis results in a discoloration of the finger nails and toe nails which is often accompanied by pain when pressure is applied to the infected nail.
  • inventions useful for treatment of pathological conditions of the nail comprise topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid.
  • Invention methods are particularly effective in treating conditions caused by microbial infections, such as fungal or bacterial infections.
  • compositions employed by invention methods have an inherently low viscosity, thereby rendering the compositions particularly useful for treating infections of the nail.
  • the low viscosity of invention compositions allows for enhanced penetration through and under the nail for prevention and treatment of infections.
  • Particular infections which are effectively treated by invention methods and compositions include fungal infections, such, for example, onychomycosis.
  • Alcohols contemplated for use in the practice of the present invention include optionally substituted methanol, ethanol, propanol, butanol, and the like.
  • Carboxylic acids contemplated for use in the practice of the present invention include formic acid or optionally substituted acetic acid, propionic acid, butyric acid, pentanoic acid, and the like.
  • substituents include —OH, alkyl, substituted alkyl, alkenyl, substituted alkenyl, aryl, substituted aryl, alkoxy, substituted alkoxy, halogen (e.g., F, Cl, Br, I), NO 2 , cyano, amino, carboxyl, amido, sulfuryl, —C(O)H, and the like.
  • alkyl refers to alkyl groups having up to about 6 carbon atoms
  • substituted alkyl refers to alkyl groups bearing one or more substituents selected from hydroxy, alkoxy, halogen (e.g., F, Cl, Br, I), NO 2 , cyano, amino, carboxyl, amido, sulfuryl, —C(O)H, and the like.
  • alkenyl refers to straight or branched chain hydrocarbyl groups having at least one carbon-carbon double bond, and having in the range of about 2 up to about 6 carbon atoms
  • substituted alkenyl refers to alkenyl groups further bearing one or more substituents as set forth in the definition of “alkyl”.
  • aryl refers to aromatic rings having up to about 10 carbon atoms
  • substituted aryl refers to aryl groups further bearing one or more substituents as set forth in the definition of “alkyl”.
  • alkoxy refers to a group —OR, wherein R is an alkyl group as defined above.
  • Preferred alcohols contemplated for use in the practice of the present invention include methanol and ethanol. Presently most preferred alcohols contemplated for use in the practice of the present invention include optionally substituted methanols.
  • Preferred carboxylic acids contemplated for use in the practice of the present invention include optionally substituted acetic acid and propionic acid. Presently most preferred carboxylic acids contemplated for use in the practice of the present invention include optionally substituted acetic acids.
  • compositions typically comprise from about 50 wt % to about 90 wt % alcohol and about 10 wt % to about 40 wt % carboxylic acid.
  • Preferred compositions comprise about 75 wt % alcohol and about 25 wt % carboxylic acid.
  • invention compositions are readily prepared by mixing the desired alcohol with the desired carboxylic acid at room temperature to provide a low viscosity, homogeneous solution. Since the components of invention compositions are low molecular weight compounds, the resulting solutions are often volatile. Accordingly, the solutions should be stored in a suitable vessel, e.g., a septum-capped container, a tightly sealed screw-cap container, and the like. In addition, since invention compositions are quite stable, the compositions can be expected to have very long shelf lives.
  • the methods and compositions of the present invention are useful in the topical treatment of any bacterial, mycotic, or other microbial infection.
  • Invention methods and compositions are particularly effective in treating infections that have not resulted in an open lesion.
  • microbial infections refers to fungal infections as well as bacterial infections.
  • Infections effectively treated by the methods and compositions of the present invention include any infections of the nail caused by a fungus, including yeasts and molds.
  • Invention compositions can be applied to the affected area in a variety of ways, e.g., by painting the nail, through use of a dropper, and the like. Invention compositions can be administered employing a variety of protocols, e.g., the compositions may be administered weekly until no sign of infection can be detected.
  • unit dosage forms comprising a container which holds therein an amount of a composition according to the present invention effective for topically treating a bacterial, mycotic, or other microbial infection.
  • Unit dosage forms of the present invention further comprise an applicator for appropriate administration of invention compositions, as well as instructions for appropriate use of invention unit dosage forms.
  • invention compositions provide several advantages over currently available treatment protocols for infections of the nail.
  • the low viscosity of invention compositions allows for penetration through and under the nail, thereby killing fungus, including fungal spores, on contact.
  • invention compositions have the ability to displace moisture present underneath the nail. Since moisture is a critical component of fungal growth, invention methods and compositions provide not only a cure for presently existing nail fungus, but also create an environment hostile to fungal growth, thereby preventing future infection. Indeed, this preventative component of the present invention provides the additional benefit of requiring only occasional administration, rather than the daily administration required by currently available nail lacquers.
  • invention methods greatly minimize patient discomfort, i.e., no surgical removal of the nail or drilling of the nail is required.
  • the components of invention compositions are readily available and inexpensive, rendering the use of invention methods and compositions economically attractive.

Abstract

In accordance with the present invention, there are provided methods for treatment of pathological conditions of the nail, said method comprising topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention methods effectively treat bacterial or fungal infections of the nail by utilizing a low viscosity composition having the ability to penetrate through and underneath the nail plate, thereby attacking the infection at its source.

Description

FIELD OF THE INVENTION
The present invention relates to methods for treating pathological conditions of the nail and compositions useful therefor. In a particular aspect, the invention relates to methods for treating conditions resulting from bacterial or fungal infections of the nail, and compositions useful therefor.
BACKGROUND OF THE INVENTION
In the field of dermatology, topical administration of pharmaceutically active agents has often been employed for treating pathological conditions. Many of the concerns associated with other types of administration can often be avoided by topically administering an active agent to a subject in need thereof. For example, reliable delivery of a pharmaceutically active agent to organs or tissues in need thereof via oral administration is often difficult due to variable rates of absorption and metabolism associated with oral delivery. In contrast, topical administration of a pharmaceutically active agent can provide high doses of the active agent directly to the infected area, and often minimizes side effects.
Although maladies of the skin can often be effectively treated by topical administration of pharmaceutically active agents, successful treatment of conditions of the nail has remained elusive. Due to the hyperkeratotic nature of the nail, pharmaceutical formulations in the form of creams, gels, and lotions are unable to penetrate the nail plate. Thus, it has proven quite difficult to effectively deliver a pharmaceutically active agent into and beneath the nail plate, where the cause of the pathological condition originates.
A particular condition of the nail which remains ineffectively treated is onychomycosis. This condition is a fungal infection of the nail most frequently caused by dermatophytes and molds. Indeed, onychomycosis refers to any dermatophyte infection of the nail plate and includes infection of nails by any fungus, such as yeast, molds, and the like. Onychomycosis results in a discoloration of the finger nails and toe nails which is often accompanied by pain when pressure is applied to the infected nail.
A number of attempts have been made to effectively treat nail fungus, each meeting with limited success. For example, surgical removal of the nail or drilling holes in the nail to allow penetration of anti-fungal topical treatments results in considerable patient discomfort; systemic administration of anti-fungal drugs suffers from the inherent difficulties involved with parenteral administration and may also result in undesirable side-effects; and anti-fungal lacquers (painted on the nail) lack the necessary penetrating power to directly reach the fungal infection.
Accordingly, there remains a need for effective treatment of pathological conditions of the nail.
BRIEF DESCRIPTION OF THE INVENTION
In accordance with the present invention, there are provided methods for treatment of pathological conditions of the nail. Invention methods comprise topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention methods effectively treat bacterial or fungal infections of the nail by utilizing a low viscosity composition having the ability to penetrate through and underneath the nail plate, thereby attacking the infection at its source.
Further provided by the present invention are compositions consisting essentially of an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention compositions kill on contact all types of microbes, including fungi and bacteria. Thus, these compositions are extremely effective in combating pathological conditions of the nail, such as, for example, onychomycosis.
DETAILED DESCRIPTION OF THE INVENTION
In accordance with the present invention, there are provided methods and compositions useful for treatment of pathological conditions of the nail. Invention methods comprise topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention methods are particularly effective in treating conditions caused by microbial infections, such as fungal or bacterial infections.
Compositions employed by invention methods have an inherently low viscosity, thereby rendering the compositions particularly useful for treating infections of the nail. The low viscosity of invention compositions allows for enhanced penetration through and under the nail for prevention and treatment of infections. Particular infections which are effectively treated by invention methods and compositions include fungal infections, such, for example, onychomycosis.
Alcohols contemplated for use in the practice of the present invention include optionally substituted methanol, ethanol, propanol, butanol, and the like. Carboxylic acids contemplated for use in the practice of the present invention include formic acid or optionally substituted acetic acid, propionic acid, butyric acid, pentanoic acid, and the like. When compounds contemplated for use in the practice of the present invention are substituted, substituents include —OH, alkyl, substituted alkyl, alkenyl, substituted alkenyl, aryl, substituted aryl, alkoxy, substituted alkoxy, halogen (e.g., F, Cl, Br, I), NO2, cyano, amino, carboxyl, amido, sulfuryl, —C(O)H, and the like.
As employed herein, “alkyl” refers to alkyl groups having up to about 6 carbon atoms, and “substituted alkyl” refers to alkyl groups bearing one or more substituents selected from hydroxy, alkoxy, halogen (e.g., F, Cl, Br, I), NO2, cyano, amino, carboxyl, amido, sulfuryl, —C(O)H, and the like.
As employed herein, “alkenyl” refers to straight or branched chain hydrocarbyl groups having at least one carbon-carbon double bond, and having in the range of about 2 up to about 6 carbon atoms, and “substituted alkenyl” refers to alkenyl groups further bearing one or more substituents as set forth in the definition of “alkyl”.
As employed herein, “aryl” refers to aromatic rings having up to about 10 carbon atoms, and “substitituted aryl” refers to aryl groups further bearing one or more substituents as set forth in the definition of “alkyl”.
As employed herein, “alkoxy” refers to a group —OR, wherein R is an alkyl group as defined above.
Preferred alcohols contemplated for use in the practice of the present invention include methanol and ethanol. Presently most preferred alcohols contemplated for use in the practice of the present invention include optionally substituted methanols. Preferred carboxylic acids contemplated for use in the practice of the present invention include optionally substituted acetic acid and propionic acid. Presently most preferred carboxylic acids contemplated for use in the practice of the present invention include optionally substituted acetic acids.
Invention compositions typically comprise from about 50 wt % to about 90 wt % alcohol and about 10 wt % to about 40 wt % carboxylic acid. Preferred compositions comprise about 75 wt % alcohol and about 25 wt % carboxylic acid.
Invention compositions are readily prepared by mixing the desired alcohol with the desired carboxylic acid at room temperature to provide a low viscosity, homogeneous solution. Since the components of invention compositions are low molecular weight compounds, the resulting solutions are often volatile. Accordingly, the solutions should be stored in a suitable vessel, e.g., a septum-capped container, a tightly sealed screw-cap container, and the like. In addition, since invention compositions are quite stable, the compositions can be expected to have very long shelf lives.
The methods and compositions of the present invention are useful in the topical treatment of any bacterial, mycotic, or other microbial infection. Invention methods and compositions are particularly effective in treating infections that have not resulted in an open lesion. As employed herein, the term “microbial infections” refers to fungal infections as well as bacterial infections. Infections effectively treated by the methods and compositions of the present invention include any infections of the nail caused by a fungus, including yeasts and molds.
Invention compositions can be applied to the affected area in a variety of ways, e.g., by painting the nail, through use of a dropper, and the like. Invention compositions can be administered employing a variety of protocols, e.g., the compositions may be administered weekly until no sign of infection can be detected.
Further provided by the present invention are unit dosage forms comprising a container which holds therein an amount of a composition according to the present invention effective for topically treating a bacterial, mycotic, or other microbial infection. Unit dosage forms of the present invention further comprise an applicator for appropriate administration of invention compositions, as well as instructions for appropriate use of invention unit dosage forms.
The present invention provides several advantages over currently available treatment protocols for infections of the nail. In contrast to currently available topical treatments, the low viscosity of invention compositions allows for penetration through and under the nail, thereby killing fungus, including fungal spores, on contact. In addition, invention compositions have the ability to displace moisture present underneath the nail. Since moisture is a critical component of fungal growth, invention methods and compositions provide not only a cure for presently existing nail fungus, but also create an environment hostile to fungal growth, thereby preventing future infection. Indeed, this preventative component of the present invention provides the additional benefit of requiring only occasional administration, rather than the daily administration required by currently available nail lacquers. Moreover, invention methods greatly minimize patient discomfort, i.e., no surgical removal of the nail or drilling of the nail is required. Finally, the components of invention compositions are readily available and inexpensive, rendering the use of invention methods and compositions economically attractive.
While the invention has been described in detail with reference to certain preferred embodiments thereof, it will be understood that modifications and variations are within the spirit and scope of that which is described and claimed.

Claims (14)

What is claimed is:
1. A method for treatment of a pathological condition of the nail, said method comprising topically applying to the affected area an effective amount of a composition consisting essentially of about 50 wt % to about 90 wt % of methanol and about 10 wt % to about 40 wt % of carboxylic acid having 1-5 carbons.
2. The method according to claim 1, wherein said pathological condition is microbial infection.
3. The method according to claim 2, wherein said microbial infection is fungal infection.
4. The method according to claim 3, wherein said fungal infection is onychomycosis.
5. The method according to claim 1, wherein said carboxylic acid having 1-5 carbons is formic acid, acetic acid, propionic acid, butyric acid, or pentanoic acid.
6. The method according to claim 5, wherein said carboxylic acid is acetic acid.
7. The method according to claim 6, wherein said composition consists essentially of about 50 wt % to about 90 wt % methanol and about 10 wt % to about 40 wt % acetic acid.
8. The method according to claim 7, wherein said composition consists essentially of about 75 wt % methanol and about 25 wt % acetic acid.
9. A method for treatment of fungal infection of the nail, said method comprising topically applying to the affected area an effective amount of a composition consisting essentially of about 50 wt % to about 90 wt % of an alcohol having 1-4 carbons and about 10 wt % to about 40 wt % of carboxylic acid having 1-5 carbons.
10. The method according to claim 9, wherein said fungal infection is onychomycosis.
11. The method according to claim 9, wherein said composition consists essentially of about 75 wt % alcohol and about 25 wt % carboxylic acid.
12. A method for the treatment of onychomycosis, said method comprising topically applying to the affected area an effective amount of a composition consisting essentially of about 75 wt % methanol and about 25 wt % acetic acid.
13. A method for treatment of a pathological condition of the nail, said method comprising topically applying to the affected area an effective amount of a composition consisting of about 50 wt % to about 90 wt % of methanol and about 10 wt % to about 40 wt % of carboxylic acid having 1-5 carbons.
14. A method for treatment of fungal infection of the nail, said method comprising topically applying to the affected area an effective amount of a composition consisting of about 50 wt % to about 90 wt % of an alcohol having 1-4 carbons and about 10 wt % to about 40 wt % of carboxylic acid having 1-5 carbons.
US09/873,773 2001-06-04 2001-06-04 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor Expired - Fee Related US6664292B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US09/873,773 US6664292B2 (en) 2001-06-04 2001-06-04 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
EP02726836A EP1401421B1 (en) 2001-06-04 2002-05-03 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
DE60235545T DE60235545D1 (en) 2001-06-04 2002-05-03 METHOD FOR THE TREATMENT OF NAIL MUSHROOM AND OTHER MICROBIAL AND MYCOTIC DISEASES AND COMPOSITIONS SUITABLE THEREFOR
AT02726836T ATE459349T1 (en) 2001-06-04 2002-05-03 METHOD FOR TREATING NAIL FUNGUS AND OTHER MICROBIAL AND MYCOTIC DISEASES AND COMPOSITIONS SUITABLE THEREFOR
PCT/US2002/014007 WO2002098402A1 (en) 2001-06-04 2002-05-03 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
JP2003501442A JP2004532882A (en) 2001-06-04 2002-05-03 Methods for treating nail fungi and other microbial and fungal infections and compositions useful therefor
ES02726836T ES2343352T3 (en) 2001-06-04 2002-05-03 PROCEDURES FOR THE TREATMENT OF FINGERS OF THE NAILS AND OTHER MICROBIAL AND MICOTIC AFFECTIONS AND USEFUL COMPOSITIONS FOR THE SAME.
CA2449312A CA2449312C (en) 2001-06-04 2002-05-03 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
AU2008201244A AU2008201244A1 (en) 2001-06-04 2008-03-17 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/873,773 US6664292B2 (en) 2001-06-04 2001-06-04 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor

Publications (2)

Publication Number Publication Date
US20020183387A1 US20020183387A1 (en) 2002-12-05
US6664292B2 true US6664292B2 (en) 2003-12-16

Family

ID=25362282

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/873,773 Expired - Fee Related US6664292B2 (en) 2001-06-04 2001-06-04 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor

Country Status (8)

Country Link
US (1) US6664292B2 (en)
EP (1) EP1401421B1 (en)
JP (1) JP2004532882A (en)
AT (1) ATE459349T1 (en)
CA (1) CA2449312C (en)
DE (1) DE60235545D1 (en)
ES (1) ES2343352T3 (en)
WO (1) WO2002098402A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
US20040197280A1 (en) * 2001-10-22 2004-10-07 Repka Michael A. Delivery of medicaments to the nail
WO2007075487A2 (en) 2005-12-19 2007-07-05 Syngenta Limited Substituted aromatic heterocyclic compounds as fungicides
US20070243222A1 (en) * 2006-02-03 2007-10-18 Carl Lawyer Fungicidal formulation and method of use
US20080167350A1 (en) * 2004-09-10 2008-07-10 Syngenta Limited Substituted isoxazoles as fungicides
US20080207537A1 (en) * 2005-06-06 2008-08-28 Medpharm Limited Topical Ungual Formulations
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
US20100145373A1 (en) * 2008-12-05 2010-06-10 Ruth Alon Nail drill
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US20110083692A1 (en) * 2009-10-09 2011-04-14 Cynthia Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of highly concentrated or supersaturated boric acid
CN103096883A (en) * 2010-09-17 2013-05-08 阿拜尔公司 Treatment of fungal infections
US8979820B2 (en) 2009-10-09 2015-03-17 Cynthia S. Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
US10456568B2 (en) 2013-03-14 2019-10-29 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135194B2 (en) * 2002-09-27 2006-11-14 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
US20070014743A1 (en) * 2002-09-27 2007-01-18 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
FR2863168A1 (en) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Antibacterial agents comprising gamma--butyrolactone degradation pathway inducers, e.g. succinate semialdehyde, useful in human or veterinary medicine, plant or foodstuff protection or disinfection
US20090192125A1 (en) * 2007-02-08 2009-07-30 Dermworx Incorporated Local anti-infective agent for treatment of nail fungal infections
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
BRPI1014488A2 (en) * 2009-05-15 2016-04-05 Biocepta Corp compositions suitable for the topical treatment of fungal skin and nail infections
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
BE1018742A3 (en) * 2010-09-02 2011-07-05 Oystershell Nv COMPOSITION FOR TREATMENT OF NAIL MEL DISEASES AND USE THEREOF.
WO2015051183A1 (en) 2013-10-03 2015-04-09 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CN105848719A (en) 2013-11-22 2016-08-10 道尔医药科学公司 Anti-infective methods, compositions, and devices

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970032A (en) * 1957-05-27 1961-01-31 Otto C Jekel Stable solutions of compounds of tannins with boric acid
US4180058A (en) 1978-08-15 1979-12-25 Jacob Brem Method of treating pathological conditions of the nail
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4986963A (en) * 1989-01-24 1991-01-22 Corcoran Richard A Method of disinfecting contact lenses with peracetic acid
US5043357A (en) * 1986-07-02 1991-08-27 Kruger Gmbh & Co. Kg Virucidal agent having broad-spectrum activity
US5145663A (en) * 1989-01-31 1992-09-08 Simmons Paul L Biodegradable disinfectant containing anhydrous alcohol and propylene glycol
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5422366A (en) 1991-12-18 1995-06-06 Advanced Oxygen Technologies, Inc. Treatment of fungal infections
US5519059A (en) 1994-08-17 1996-05-21 Sawaya; Assad S. Antifungal formulation
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
WO1996036311A1 (en) * 1995-05-18 1996-11-21 Hoechst Aktiengesellschaft Use of glyceryl triacetate for treating onychomycoses
US5613538A (en) * 1995-10-18 1997-03-25 Denis Comact Inc. Knife holder for timber shaping and chip producing head
US5641475A (en) * 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
US5652256A (en) 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US5814305A (en) 1991-03-08 1998-09-29 Novartis Ag Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
US5853767A (en) 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
US5916545A (en) 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US5993790A (en) 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US6066670A (en) * 1994-06-08 2000-05-23 Brown; Raymond K. Therapeutic compositions and methods of use
WO2001012173A1 (en) * 1999-08-13 2001-02-22 Effcon Laboratories, Inc. Low concentration pest treatment composition and method
US6231840B1 (en) 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
US20010025058A1 (en) * 2000-02-23 2001-09-27 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds
US20020004057A1 (en) * 1998-04-30 2002-01-10 Renato Tabasso Method for production on the spot of a disinfectant peracetic acid system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547988B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid

Patent Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2970032A (en) * 1957-05-27 1961-01-31 Otto C Jekel Stable solutions of compounds of tannins with boric acid
US4180058A (en) 1978-08-15 1979-12-25 Jacob Brem Method of treating pathological conditions of the nail
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
US5043357A (en) * 1986-07-02 1991-08-27 Kruger Gmbh & Co. Kg Virucidal agent having broad-spectrum activity
US5641475A (en) * 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
US5807890A (en) * 1987-05-15 1998-09-15 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
US4986963A (en) * 1989-01-24 1991-01-22 Corcoran Richard A Method of disinfecting contact lenses with peracetic acid
US5145663A (en) * 1989-01-31 1992-09-08 Simmons Paul L Biodegradable disinfectant containing anhydrous alcohol and propylene glycol
US5814305A (en) 1991-03-08 1998-09-29 Novartis Ag Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions
US5422366A (en) 1991-12-18 1995-06-06 Advanced Oxygen Technologies, Inc. Treatment of fungal infections
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5916545A (en) 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US6066670A (en) * 1994-06-08 2000-05-23 Brown; Raymond K. Therapeutic compositions and methods of use
US5519059A (en) 1994-08-17 1996-05-21 Sawaya; Assad S. Antifungal formulation
WO1996036311A1 (en) * 1995-05-18 1996-11-21 Hoechst Aktiengesellschaft Use of glyceryl triacetate for treating onychomycoses
US5889039A (en) 1995-06-06 1999-03-30 Knowles; W. Roy Topical composition for fungal treatment
US5652256A (en) 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US5613538A (en) * 1995-10-18 1997-03-25 Denis Comact Inc. Knife holder for timber shaping and chip producing head
US5853767A (en) 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
US5993790A (en) 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US6231840B1 (en) 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
US20020004057A1 (en) * 1998-04-30 2002-01-10 Renato Tabasso Method for production on the spot of a disinfectant peracetic acid system
WO2001012173A1 (en) * 1999-08-13 2001-02-22 Effcon Laboratories, Inc. Low concentration pest treatment composition and method
US20010025058A1 (en) * 2000-02-23 2001-09-27 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Scott, W. Antifungal agent, Database IPA, AN:71:194, abstract, Hospital pharmacy, 1971, vol.6, pp. 17-20. *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
US7959904B2 (en) * 2001-10-22 2011-06-14 University Of Mississippi Delivery of medicaments to the nail
US20040197280A1 (en) * 2001-10-22 2004-10-07 Repka Michael A. Delivery of medicaments to the nail
US20080167350A1 (en) * 2004-09-10 2008-07-10 Syngenta Limited Substituted isoxazoles as fungicides
US7998983B2 (en) 2004-09-10 2011-08-16 Syngenta Limited Substituted isoxazoles as fungicides
US20080207537A1 (en) * 2005-06-06 2008-08-28 Medpharm Limited Topical Ungual Formulations
WO2007075487A2 (en) 2005-12-19 2007-07-05 Syngenta Limited Substituted aromatic heterocyclic compounds as fungicides
US20070243222A1 (en) * 2006-02-03 2007-10-18 Carl Lawyer Fungicidal formulation and method of use
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
US20100145373A1 (en) * 2008-12-05 2010-06-10 Ruth Alon Nail drill
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US20110083692A1 (en) * 2009-10-09 2011-04-14 Cynthia Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of highly concentrated or supersaturated boric acid
US8979820B2 (en) 2009-10-09 2015-03-17 Cynthia S. Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
CN103096883A (en) * 2010-09-17 2013-05-08 阿拜尔公司 Treatment of fungal infections
US8921425B2 (en) 2010-09-17 2014-12-30 Abbell Ab Treatment of fungal infections
US10456568B2 (en) 2013-03-14 2019-10-29 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit

Also Published As

Publication number Publication date
ATE459349T1 (en) 2010-03-15
DE60235545D1 (en) 2010-04-15
US20020183387A1 (en) 2002-12-05
CA2449312C (en) 2011-11-22
CA2449312A1 (en) 2002-12-12
WO2002098402A1 (en) 2002-12-12
ES2343352T3 (en) 2010-07-29
EP1401421B1 (en) 2010-03-03
JP2004532882A (en) 2004-10-28
EP1401421A1 (en) 2004-03-31
EP1401421A4 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
US6664292B2 (en) Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US6231875B1 (en) Acidified composition for topical treatment of nail and skin conditions
ES2477556T3 (en) Topical composition comprising N-acetyl-glucosamine
JP5198846B2 (en) Methods and compositions for burned skin
JP2003514875A (en) Propellant-free spray-on skin patch composition for improving wound healing and administering medication
CA2002404A1 (en) Delivery system for pharmaceutical or therapeutic actives
KR910014117A (en) Transdermal Delivery Method of Ibuprofen Using Hydroalcoholic Gel
US20080027033A1 (en) Method and Composition for Treatment of Cutaneous Lesions
US4352794A (en) Beta-cyclodextrin as anti-acne agent
KR101333892B1 (en) Antifungal composition
KR950003919B1 (en) Process for preparing topical metronidazole formulations
JP2012504624A (en) Topical treatment of skin infections
US6680073B1 (en) Composition and method for the treatment of onychomycosis in animals
CA2528431A1 (en) Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
AU2002257242A1 (en) Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
AU2008201244A1 (en) Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
JPH01110620A (en) Antifungal composition
WO2002022115A2 (en) Methods and compositions for treating nail fungus
EP2431030B1 (en) Treatment of fungal infections
US5576005A (en) Effectiveness of wart removal by compositions including propolis
US20050123491A1 (en) Composition and method for treating onychomycosis
AU2003246031A8 (en) An acidified composition for topical treatment of nail and skin conditions
MXPA00009631A (en) An acidified composition for topical treatment of nail and skin conditions

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment

Year of fee payment: 7

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20151216